CAPITULO V REFERENCIA BIBLIOGRÁFICA 1. Hook

Respuesta Inicial al Tratamiento con Hormona de Crecimiento en un
Grupo de Once Pacientes con Síndrome de Turner. Ticona Bedía, Jesús
Carlos.
Derechos reservados conforme a Ley
CAPITULO V
REFERENCIA BIBLIOGRÁFICA
1. Hook EB, Propugnan JL. The frecuency of chromosome abnormalities detected
in consecutive newborn studies, differences between studies: results by sex and
severity of phenotypic involvement. In: Population Citogenetics, Hookes B,
Porter IH (Eds). Academic Press, New York, 1977, p 63.
2. Hookm EB, Warburton D. The distribution of chromosomal genotypes
associated with Turner's syndrome: live birth prevalence rates and evidence for
diminished fetal mortality and severity in genotypes associated with structural X
abnormalities or mosaics. Hum Genet 1983, 64:24.
3. Jacobs P, Betts Pr, Rockwell AE, et al. A biogenetic and molecular reappraisal
of a series of patients with Turner's syndrome. Ann Hum Genet 1990; 54:209.
4. Nielsen J, Wohlert M. Chromosome abnormalities found among 34910 newborn
children: Results from a 13-year incidence study in Aarhus Denmark. Hum
Genet 1991; 87:81.
5. Turner HH. A syndrome of infantilism, congenital Webbed neck, and cubitus
valgus. Endocrinology 1938; 28:566.
6. Cockwell A, mac Kenzie M, Yoouings S, Jacobs P. A citogenetic and molecular
study of a series of 45, X fetuses and their parents. J Med Genet 191; 28:152.
7. Saenger p. Turner's syndrome. N Engl J MED 1996; 335:1749.
Elaboración y diseño en formato PDF por la Oficina General del Sistema de Bibliotecas y Biblioteca Central de la UNMSM
Respuesta Inicial al Tratamiento con Hormona de Crecimiento en un
Grupo de Once Pacientes con Síndrome de Turner. Ticona Bedía, Jesús
Carlos.
Derechos reservados conforme a Ley
8. Lippe BM, Turner syndrome. En Pediatric Endocrinology 3rd ed, Sperling, M
(ED) WB Saunders, Philadelphia, 1996, p. 387.
9. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner's syndrome.
Arch Dis Child 1985; 60: 932-935.
10. Ranke MB, Pfluger H, Rosendahl W, et al. Turner syndrome: Spontaneous
growth in 150 cases and review of the literature. Eur J Pediatr 1983; 141:81.
11. Rongen-Westerlaken C, Corel L, Vanden Brocck J, et al. Reference values
for height, height velocity and weight in Turner's syndrome. Acta Paediatr
1997; 86:937-42.
12. Sylven L, Hagenfeldt k, Brondum-Nielsen K, Von Schoultz B. Middle-aged
women with Turner' syndrome: Medical status, hormonal treatment and social
life. Acta Endocrinol (Copenh) 1991; 125:359.
13. Chiovato L, Larissa D, Bendinelli G, et al. Autoinmune hypothyroidism and
hyperthyroidism in patients with Turner's syndrome. Eur J Endocrinol 1996;
134:568.
14. Gravholt Ch, Juul S, Naeraa R, et al. Morbidity in Turner syndrome. J Clin
Epidemiol 1998; 51:147.
15. Pasquino A, Passeri F, Pucarelli I, et al. Spontaneous pubertal development in
Turner syndrome. J C Endocrinol Metab 1997; 82:1810.
16. Landin-Wilhemsen K, Bryman I, Windh M, et al. Osteoporosis and fractures in
Turner's syndrome importance of growth promoting and oestrogen therapy. Clin
Endocrinol (Oxf) 1999; 51:497.
Elaboración y diseño en formato PDF por la Oficina General del Sistema de Bibliotecas y Biblioteca Central de la UNMSM
Respuesta Inicial al Tratamiento con Hormona de Crecimiento en un
Grupo de Once Pacientes con Síndrome de Turner. Ticona Bedía, Jesús
Carlos.
Derechos reservados conforme a Ley
17. Hall J, Gilchrist D. Síndrome de Turner y sus variantes. Clin Ped Norteamérica
1481-1496.
18. Sauvion S, Brauner R, Rappaport R. Syndrome de Turner: aspects endocriniens.
La Medicine Infantile 1990:1:17-21.
19. Brook C. Turner sindrome. Arch Dis Child; 1986:35:305-309.
20. Rosenfeld, Hintz R: Growth hormone therapy in Turner syndrome. En:
Underwood L, ed. Human growth hormone, progress and challenges. New
York: Manuel Dekker inc, 1988: 193-205.
21. Singh R, Carr D. The anatomy and histology of XO human embryos and fetuses.
Anat Rec 1996; 155:369.
22. King C, Magenis E, Bennett S. Pregnancy and the Turner syndrome. Obst
Gynecol 1978;52:617.
23. Reyes F, Koh K, Faiman C. Fertility in warten with gonadal disgenesis. Am J
Obstet Gynecol 1976; 126:668.
24. Bernasconi S., et al. Turner's syndrome height chart. Acta Paediatr 1994;83:292.
25. Rosenfeld R, Tesch L, Rodríguez J, et al. Recommendations for diagnosis,
treatment and management of individuals with Turner syndrome. The
Endocriologist 1994, 4:351-358.
26. Rodríguez Hierro F, Torres M, Ferrer A. Síndrome de Turner. En: Algoritmos
diagnóstico-Terapéuticos Endocrinología Pediátrica. Hermes Gráficos, MadridEspaña; l997:191-197.
Elaboración y diseño en formato PDF por la Oficina General del Sistema de Bibliotecas y Biblioteca Central de la UNMSM
Respuesta Inicial al Tratamiento con Hormona de Crecimiento en un
Grupo de Once Pacientes con Síndrome de Turner. Ticona Bedía, Jesús
Carlos.
Derechos reservados conforme a Ley
27.
Rodríguez Hierro F. Disgenesias gonadale s. En: Argente J, Carrascosa A, Gracia
R, Rodriguez F, editores. Tratado de Endocrinología Pediátrica y de la
Adolescencia; 2da ed Ediciones Doyma, SL Barcelona; 2000:797-807.
28.
Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations:
deduction of the principal factors involved on the development of clinical
features. Hum Genet 1995; 95:607-629.
29.
Zinn A, Ross L. Critical regions for Turner syndrome phenotypes on the X
chromosome. En: Saenger Pk Pasquino AM; editors. Proceedings of the 5th
International Turner Symposium. Optimizing Health Care for Turner Patients
in the 21st Century. 23-25 Marzo del 2000. Nápoles, Italia.
30.
Mayayo E, Labarto J, Ferrández A. Pubertad retrasada. Hipogonadismos.
En: Pombo M, Argemí J, Audí L, Borrajo E, et al., editores. Tratado de
Endocrinología Pediátrica. Segunda Edición; Ediciones Díaz de Santos SA,
Madrid España; 1997: 737-762.
31.
López J, Moreno J, Martínez-Aedo M, Villegas E, Gallo M, Vallejo E, et al.
Preguntas y Respuestas sobre el síndrome de Turner. Novo Nordisk Pharma, SA.
Madrid-España: 1977.
32.
Massa G, Vanderschueren Lodeweyckx M. Age and height at diagnosis in
Turner síndrome: influence of parental height. Pediatrics 1991; 88:1.148-1.152.
33.
Elsheik M, Dunger D, Conway G, Wass J. Turner's syndrome in adulthood.
Endocríne Reviews, February 2002, 23(1):120-140.
34.
Ulrich
O.
Uber
typische
kombinationsbilder
multiper
Albartunger.
Kinderheilk 1930; 49:271-276.
Elaboración y diseño en formato PDF por la Oficina General del Sistema de Bibliotecas y Biblioteca Central de la UNMSM
Respuesta Inicial al Tratamiento con Hormona de Crecimiento en un
Grupo de Once Pacientes con Síndrome de Turner. Ticona Bedía, Jesús
Carlos.
Derechos reservados conforme a Ley
35.
American Academy of Pediatrics, committee on drugs and committee on
bioethics considerations related to the use of recombinant human growth
hormone in children. Pediatrics vol 99 N°1, January 1997,122-129.
36.
RosenfeId R, Fiane J, Attie K, et al. Six year results of a randomized,
prospective trial of human growth hormone and oxandrolone in Turner
syndrome. J Pediatr 1992;121:49-51.
37.
Hindmarsh P, Brook C. Effect of growth hormone on short normal children. Br
Med J. 1987; 295:573-577.
38.
Grunt J, Enriquez A. Acute and long-term responsiveness growth hormone in
children with short stature. Pediatr Res 1992; 6:664-674.
39.
Sas T, Muinck Keizer-Schrama S, Stijnen T, Van Teunenbroek A, HokkenKoelega Ac, Walkens J, et al. Final height in girls with Turner'syndrome treated
with once or twice daily growth hormone injections. Dutch Advisory Group on
Growth Hormone. Arch Dis Child 1999; 80:36-41.
40.
Betts P, Butler G, Donaldson M, Dunger D, Hohnston D, Kelnar C, et al. A
decade of growth hormone treatment in girls with Turner syndrome in the UK.
KIGS Executive Group. Arch Dis Child 1999; 80:221-225.
41.
Ross J, Long L, Lorie D, Cutler Jr G. Growth hormone secretory dinamics in
Turner syndrome. J Pediatr 1985; 106:202-206.
42.
Ranke M, Blum W, Haug F, Rosendahl W, Attanasio A, Enders H, Grupta D,
Bierich J. Growth hormone, somatomedin levels and growth regulation in Turner
syndrome. Acta Endocrinol (Copenh) 1987; 1 16:305-313.
Elaboración y diseño en formato PDF por la Oficina General del Sistema de Bibliotecas y Biblioteca Central de la UNMSM
Respuesta Inicial al Tratamiento con Hormona de Crecimiento en un
Grupo de Once Pacientes con Síndrome de Turner. Ticona Bedía, Jesús
Carlos.
Derechos reservados conforme a Ley
43.
Reiter J, Craen M, Van-Vliet G. Decreased growth hormone response to growth
releasing hormone in Turner's syndrome: relation to body weight and adiposity.
Acta Endocrinol (copenh) 1991; 125:38-42.
44.
Azcona C, Barelli P, Stanhope R. Lesson of the week: Turner's syndrome
mosaicism in patients with a normal blood lynphocyte karyotype. Br Med J
1999; 318:856-857.
45.
Saenger P. Growth-promoting strategies in Turner's syndrome; J clin
Enndocrinol Metab 1999; 84:4345-4348.
46
Carel C, Mathivon L, Gendrel C, Ducret J, Chaussan J. Near normalization of
final height with adapted doses of growth hormone in Turner's syndrome. J Clin
Endocrinol Metab 1998; 83:1462-1466.
47.
Cacciari E, Mazzanti L. Final height of patients with Turner's syndrome with
growth hormone (GH): indications for GH therapy alone at high doses and late
estrogen therapy. Italian Study Group for Turner syndrome. J Clin Endocrinol
Metab 1999; 84:4510-4515.
48.
Tanner J, Whitehouse R, Takaishi M. Standards from birth to maturity for
height, weight, height velocity and weight velocity: British children, 1965: Arch
Dis Child 41:613-635.
49.
Greulich W, Pyle S. Radiographic Atlas of skeletal development of the hand
and wrist. 2nd edition. Standford University Press, California, USA, 1959.
50.
Kühnel
W.
IMMULITE®
and
IMMULITE®
2000
reference
range
compendium. First english edition. DPC Bierman, Germany, 2000.
Elaboración y diseño en formato PDF por la Oficina General del Sistema de Bibliotecas y Biblioteca Central de la UNMSM
Respuesta Inicial al Tratamiento con Hormona de Crecimiento en un
Grupo de Once Pacientes con Síndrome de Turner. Ticona Bedía, Jesús
Carlos.
Derechos reservados conforme a Ley
51.
NCEP. Report of the expert panel on blood cholesterol levels in childrens and
adolescents. Pediatrics, 1992; 89 (Suppl):525-583.
52.
Davenport M, Punyasavatsut N, Stewart P, Gunther D, Savendahl L. Growth
failure in Turner syndrome: it may be earlier than you thought. En: Saenger
P, Pasquino A, eds: Optimizing Health Care for Turner Patients in the 21 st
Century. Elsevier. Proceedings of the 5th International Turner Symposium
held in Naples on 23-25 March 2000: 155-161.
53.
Ferrández A, Labarta J, Calvo M, Mayayo E, Puga B, Cáncer M, et al. Síndrome
de Turner. En: Pombo M, ed. Tratado de Endocrinología Pediátrica. Tercera
edición. McGraw-Hill Interamericana, Madrid, España 2002: 780-803.
54.
De Sanctis V, Pinamonti A. Manual of disease-specific growth charts and body
standard measurements. Limited edition exclusive for Pharmacia & Upjohn.
Pacini editore. Pisa, Italy 1997: 106-114.
55.
Nilsson K, Albertsson-Wikland K, Alm J, Aronson S, Clustafsson J, Hagenas L,
et al. Improved final height in girls with Turner's syndrome treated with growth
hormone and Oxandrolone. J Clin Endocrinol Metab 1996; 81 : 635 – 640.
56.
Ranke M, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson Wikland
K, et al. Prediction of long-term response to recombinant human growth
hormone in Turner syndrome: Development and validation of mathematical
models. J Clin Endocrinol Metab 2000; 85: 4212-4218.
57.
Rosenfeld R, Attie K, Frane J, Brasel J, Burstein S, Cara J, et al. Growth
hormone therapy of Turner's syndrome: Beneficial effect on adult height. J
Pediatr 1998; 132: 319-324.
Elaboración y diseño en formato PDF por la Oficina General del Sistema de Bibliotecas y Biblioteca Central de la UNMSM
Respuesta Inicial al Tratamiento con Hormona de Crecimiento en un
Grupo de Once Pacientes con Síndrome de Turner. Ticona Bedía, Jesús
Carlos.
Derechos reservados conforme a Ley
58.
Heinrich C, Shepper J, Tomas M. et al. Final Height in 46 girls with Turner
syndrome treated with growth hormone in Belgium: evaluation of height
recovery and predictive factors. Turner syndrome in a life-span perspective
research and Clinical aspects. Albertsson Wikland K, Ranke M (eds). Elsevier
Science, Amsterdam, 1995;137-146.
59.
Quigley Ch, Crowe B, Anglin D, Chipman J. Growth hormone and low dose
estrogen in Turner syndrome: Results of a United States multi-center trial to
near-final height. The U. S. Turner Syndrome Study Group. J Clin Endocrinol
Metab 2002; 87: 2033-2041.
60.
Van Teunenbroek A, De Muinck Keizer-Schrama SM, Stijnen M, Jansen M,
Otten B, Delemarre-Van de Waal H, et al. Yearly stepwise increments of the
growth hormone dose results in a better growth response after four years in girls
with Turner syndrome. Dutch Working Group on Growth Hormone. J Clin
Endocrinol Metab 1996; 81: 4013-4021.
61.
Sas T, De Muinck Keizer-Schrama S, Stijnen T, Jansen M, Otten B, Gera
Hoorweg-Nijman J, et al. Normalization of height in girls with Turner syndrome
after long-term growth hormone treatment: Results of a Randomized dose
response trial. J Clin Endocrinol Metab 1999: 84: 4607-4612.
62. Muinck Keizer-Schrama S, Sas T. Final height in Turner syndrome: Dutch
study. 5th International Turner Symposium. Optimizing Health Care for Turner
Patients in the 21 st. Century. 23-25 de Marzo del 2000. Nápoles, Italia.
63. Van Pareren Y, De Muinck Keizer-Schrama S, Stijnen T, Sas T, Jansn M, Otten
B, et al. Final height in girls with Turner syndrome after long-term growth
hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol
Metab 2003; 88: 1119-1125.
Elaboración y diseño en formato PDF por la Oficina General del Sistema de Bibliotecas y Biblioteca Central de la UNMSM
Respuesta Inicial al Tratamiento con Hormona de Crecimiento en un
Grupo de Once Pacientes con Síndrome de Turner. Ticona Bedía, Jesús
Carlos.
Derechos reservados conforme a Ley
64. Van de Broek J, Massa G, Atanasio A, Mataranaga A, Chaussain J, Price D, et
al. Final height alter long term growth hormone treatment in Turner syndrome.
Dutch Growth Foundation. J Pediatr 1995; 127: 729-735.
65. Vásquez J, Fernández J, Martín C, Salieron M, Roca A, de la Fuente P. El
síndrome de Turner: Crecimiento, estudios hormonales y otros aspectos. An Esp
Pediatr 1997; 46:357-361.
66. Chernausek S, Attie K, Cara J, Rosenfeld R, Frane J. Growth hormone therapy
of Turner syndrome: The impact of age of estrogen replacement on final height.
J Clin Endocrinol Metab 2000; 85: 2439-2445.
67. Saenger P, Albertsson-Wikland K, Conway G, Davenport M, Gravholt C, Hintz
R, et al.
Recommendations for the diagnosis and management of Turner
syndrome. J Clin Endocrinol Metab 2001; 86:3061-3069.
68. Cunniff Ch, Hersh J, Hoyme H, kaye C, Moeschler J, Schaefer G, et al. Health
supervision for children with Turner syndrome.
Academy of Pediatrics.
Pediatrics 2003; 111.
Elaboración y diseño en formato PDF por la Oficina General del Sistema de Bibliotecas y Biblioteca Central de la UNMSM